Study Stopped
Study has been closed to accrual earlier than anticipated and will not resume.
A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
Development and Feasibility of a Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
1 other identifier
interventional
73
1 country
1
Brief Summary
This project assesses the feasibility of utilizing the geriatric assessment as a tool to identify distressed older caregivers of older adults with cancer. The investigator will engage key stakeholders including older caregivers of older adults with cancer, experts in geriatric oncology and primary care physicians to develop and pilot a supportive care intervention to improve outcomes in older caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2021
CompletedStudy Start
First participant enrolled
December 7, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2023
CompletedJanuary 6, 2025
February 1, 2024
1.7 years
August 3, 2021
January 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percentage of participants who enroll and complete the GA
Percentage of participants who were approached, enrolled in the study and completed the GA will be determined.
8 weeks per participant
Time for caregivers to complete the GA
Time to complete the GA per caregiver will be determined by summing the time to complete self-administered and clinic portions of GA.
8 weeks per patient
Caregiver satisfaction with completing the GA
Caregivers will complete a questionnaire to assess satisfaction with completing the GA
8 weeks per patient
Secondary Outcomes (1)
Percentage of caregiver supportive care recommendations that are implemented by patient/caregiver physicians
4 weeks
Study Arms (1)
Experimental
EXPERIMENTALParticipants will receive a geriatric assessment which consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on participant responses, tailored recommendations will be provided.
Interventions
The Delphi method, a process used to arrive at a group opinion or decision by surveying a panel of experts, will be used with experts in geriatric oncology to develop a supportive care management intervention for older caregivers of older adults with cancer.
Focus group qualitative interviews will be conducted with key stakeholders consisting of older adults with cancer and their caregivers.
Qualitative interviews will be conducted with older caregivers of older adults with cancer to inquire about their experience with caregiving and unmet supportive care needs.
Eligibility Criteria
You may qualify if:
- Patient and caregiver be aged 65 or older
- Patient with a diagnosis of solid tumor malignancy or lymphoma, any stage
- Patients who have initiated a new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy) OR are being considered for new line of treatment (surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy).
- Patients and caregivers must be able to provide informed consent, or if it is determined that they do not have decision-making capacity, a patient-designated health care proxy must sign consent per institutional University of Rochester and Research Subject Review Board policies on consent for incapacitated/decisionally impaired subjects.
You may not qualify if:
- Patient or caregiver is less than 65 years of age
- Patient and caregivers who do not have decision-making capacity (decisionally or cognitively impaired) AND do NOT have a previously designated health care proxy available to sign consent.
- Caregivers enrolled in phase I
- Patient and caregiver have completed a GA
- Patient and caregiver have not completed a GA
- Member of SCOREboard Community Advisory Board
- Aged 65 years or older
- Has been a family member, partner, friend or caregiver to an older adult with cancer
- Members of the Cancer and Aging Research Group
- Primary care physicians who care for older adults
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sindhuja Kadambi
Univ. of Rochester Wilmot Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Instructor - Department of Medicine , Hematology/Oncology (SMD)
Study Record Dates
First Submitted
August 3, 2021
First Posted
February 17, 2022
Study Start
December 7, 2021
Primary Completion
August 11, 2023
Study Completion
August 11, 2023
Last Updated
January 6, 2025
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- The data will be available for 7 years from accrual of the first subject.
A complete and final study protocol will be made publicly available through the University of Rochester Cancer Center Community Oncology Research Program Research Base Protocol and Data Sharing Committee. The full protocol and data will be made publicly available no later than the publication date of the study findings from the final dataset. The protocol will include a detailed description of the study population, hypotheses tested, measurement and assessment information, data definitions and codes, and the analysis plan utilized. We will be collecting identifying information. The final dataset will be stripped of identifiers prior to release for sharing. Published papers will be made available in portable document format.